Nisa Investment Advisors
AQST icon

Nisa Investment Advisors’s Aquestive Therapeutics AQST Stock Holding History

Nisa Investment Advisors’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.42K Hold
343
– – ﹤0.01% 2676
2025
Q4 		$2.22K Hold
343
– – ﹤0.01% 2591
2025
Q3 		$1.92K Hold
343
– – ﹤0.01% 2630
2025
Q2 		$1.14K Buy
343
+242
+240% +$694 ﹤0.01% 2710
2025
Q1 		$293 Sell
101
-88
-47% -$266 ﹤0.01% 2876
2024
Q4 		$673 Sell
189
-16
-8% -$74 ﹤0.01% 2764
2024
Q3 		$1.02K Buy
+205
New +$798 ﹤0.01% 2570
2021
Q1 		– Sell
-65,000
Closed -$348K – 2299
2020
Q4 		$348K Buy
+65,000
New +$390K ﹤0.01% 1278

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Nisa Investment Advisors's AQST Position: Q1 2026 in Review

Nisa Investment Advisors held its Aquestive Therapeutics (AQST) position steady in Q1 2026 at 343 shares worth $1.42K. The position accounts for ﹤0.01% of the portfolio, ranked #2676.

Nisa Investment Advisors first reported a position in AQST in Q4 2020 and has held it in 8 quarters since. The position peaked at $348K in Q4 2020. 179 funds tracked by Wall St. Rank hold AQST as of Q1 2026.

  • Nisa Investment Advisors held 343 shares of Aquestive Therapeutics worth $1.42K as of Q1 2026.
  • Nisa Investment Advisors left its Aquestive Therapeutics share count unchanged in Q1 2026.
  • Aquestive Therapeutics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #2676 holding.
  • Nisa Investment Advisors first reported a position in Aquestive Therapeutics in Q4 2020 and has held it in 8 quarters since.
  • Nisa Investment Advisors's Aquestive Therapeutics position peaked at $348K in Q4 2020.
  • 179 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.